Fennec Pharmaceuticals (FENC) Profit After Tax (2010 - 2026)

Fennec Pharmaceuticals (FENC) has 16 years of Profit After Tax data on file, last reported at -$4.8 million in Q4 2025.

• Quarterly Profit After Tax fell 141.16% year-over-year to -$4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$9.7 million (down 2134.4% YoY) and the FY2025 annual result came in at -$9.7 million, down 2134.17% from the prior year.
• Profit After Tax declined to -$4.8 million in Q4 2025, from -$638000.0 in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $12.8 million in Q1 2024 to a low of -$8.0 million in Q3 2022.
• A 5-year average of -$3.3 million and a median of -$4.2 million in 2021 frame the typical range for Profit After Tax.
• The widest YoY moves for Profit After Tax: up 312.11% in 2024, down 207.18% in 2024.
• Tracing FENC's Profit After Tax over 5 years: stood at -$4.3 million in 2021, then plunged by 58.04% to -$6.7 million in 2022, then surged by 60.12% to -$2.7 million in 2023, then advanced by 25.99% to -$2.0 million in 2024, then sank by 141.16% to -$4.8 million in 2025.
• The last three Profit After Tax figures came in at -$4.8 million (Q4 2025), -$638000.0 (Q3 2025), and -$3.2 million (Q2 2025), per Business Quant data.